Abstract:This study by Langton et al 1 explores the association between maternal family history and the development of uterine fibroids among a cohort of Black women who were fibroid-free at baseline. By ascertaining maternal fibroid history through direct surveying of the mothers, Langton et al 1 provide a more robust assessment of family history of fibroids than has been captured previously using variable methods. Despite this enhanced method, this investigation by Langton et al 1 offers a critical example of how structural racism intersects with health services delivery that affects the fundamental epidemiologic understanding of a medical condition disproportionately experienced by Black women. At its most essential level, the field of epidemiology involves the counting of incident occurrences of a disease or health outcome. However, for conditions like uterine fibroids, the counting of cases cannot be isolated from the systemically racist history of reproductive health care in the US. 2 The field of obstetrics and gynecology has its origins in the exploitation of and experimentation on Black and poor women, with the vestiges of this troubled legacy impacting gynecologic care delivery today. 3 By modern standards, Black women have less access to high-quality reproductive health care, which can influence the detection and diagnosis of gynecologic conditions, like uterine fibroids. When diagnosed, Black women are known to have higher incidence rates of uterine fibroids than other women and are more likely to be diagnosed at younger ages. 4 ,5 Prior work has qualitatively and quantitatively described experiences of racial discrimination and dismissal of symptoms among Black women with uterine fibroids. 6 In their study, Langton et al 1 found that having a positive maternal history of fibroids greatly increased the risk of incident fibroid development in adult daughters. Importantly, Langton et al 1 also found that 24% of potential participants entering the cohort believed themselves to be fibroid-free but were found to have fibroids in ultrasonographic examination. Therefore, while directly surveying the mothers represents an improvement over prior family history methods, it likely remains an underestimation of true maternal disease burden that exists. The presence of a mother reporting a fibroids diagnosis represents a particularly high level of access to health care that emphasizes the complex associations between health care delivery and epidemiology for conditions like uterine fibroids. While the detection of fibroids on cohort entry was incidental to the main study findings, 1 it highlights the substantial underdiagnosis of uterine fibroids in Black women, which may suggest an overall underascertainment of the magnitude of racial inequities that exist for uterine fibroids at a population level. 7 When considering the epidemiologic burden of disease, it must be interrogated whether the absence of a diagnosis truly reflects the absence of a disease. In understanding the population-level burden of disease for conditions like uterine fibroids we must ask ourselves who, and what counts? Epidemiology does not exist in a sociopolitical vacuum, underscoring the need for multiple domains of expertise in characterizing disease burden. Published: April 3, 2024. doi:10.1001/jamanetworkopen.2024.4165 Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2024 Roberson ML. JAMA Network Open . Corresponding Author: Mya L. Roberson, MSPH, PhD, Gillings School of Global Public Health, Department of Health Policy and Management, University of North Carolina at Chapel Hill, 1106B McGavran Greenberg Hall, 135 Dauer Dr, CB#7411, Chapel Hill, NC 27599-7411 (Mya_Roberson@unc.edu). Conflict of Interest Disclosures: None reported.

Cervical neoplasia-related factors and decreased prevalence of uterine fibroids among a cohort of African American women

Uterine Fibroid Prevalence in a Predominantly Black, Chicago-Based Cohort

Uterine Fibroids and the Risk of Cardiovascular Disease in the Coronary Artery Risk Development in Young Adult Women's Study

Uterine fibroids and risk of hypertensive disorders of pregnancy - results from a racially diverse high-risk cohort

Clinicopathologic and molecular genetic comparison of primary uterine serous adenocarcinomas from African American and Caucasian women.

Abstract C017: Race-Specific Patterns of Vaginal Microbiome and HPV Infections Predict Risk of Precancerous Cervical Lesions

Increased risk of atrial fibrillation in patients with uterine fibroids: a nationwide population-based study

Family History and Uterine Fibroid Development in Black and African American Women

Altered extracellular matrix-related pathways accelerate the transition from normal to prefibroid myometrium in Black women

Uterine fibroids and longitudinal profiles of the vaginal microbiota in a cohort presenting for transvaginal ultrasound

Abstract C163: Interaction of germline genetic variation and environmental factors in endometrial cancer prevalence in a population biobank

Association of fibroids, endometriosis, and gynecologic surgeries with breast cancer incidence and hormone receptor subtypes

Structural Racism, Health Services Research, and Burden of Uterine Fibroids

Body Mass Index and Uterine Fibroid Development: A Prospective Study

Diabetes and Uterine Fibroid Diagnosis in Midlife: Study of Women's Health Across the Nation (SWAN)

Prevalence of Advanced, Precancerous Colorectal Neoplasms in Black and White Populations: A Systematic Review and Meta-analysis

Abstract B101: Knowledge, attitudes, and self-efficacy toward cancer genetic testing among Black women with and without breast cancer

Abstract C154: Clinical, genomic, and socioeconomic factors underlying low survival rates from colorectal cancer in African American patients

Abstract 6119: Association of genetic African ancestry and triple-negative breast cancer risk: Findings from the African-ancestry breast cancer genetics consortium

The Association Between Subclinical Atherosclerosis And Uterine Fibroids

Abstract B150: Social determinants of health and comorbidities increasing inflammation cytokines related to breast cancer in African American and Latinx women